FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617142754> ?p ?o ?g. }

• W2617142754 endingPage "1303" @default.
• W2617142754 startingPage "1298" @default.
• W2617142754 abstract "BACKGROUND: It remains unknown whether continuous or scheduled intermittent bolus local anesthetic administration is preferable for transversus abdominis plane (TAP) catheters. We therefore tested the hypothesis that when using TAP catheters, providing local anesthetic in repeated bolus doses increases the cephalad-caudad cutaneous effects compared with a basal-only infusion. METHODS: Bilateral TAP catheters (posterior approach) were inserted in 24 healthy volunteers followed by ropivacaine 2 mg/mL administration for a total of 6 hours. The right side was randomly assigned to either a basal infusion (8 mL/h) or bolus doses (24 mL administered every 3 hours for a total of 2 bolus doses) in a double-masked manner. The left side received the alternate treatment. The primary end point was the extent of sensory deficit as measured by cool roller along the axillary line at hour 6 (6 hours after the local anesthetic administration was initiated). Secondary end points included the extent of sensory deficit as measured by cool roller and Von Frey filaments along the axillary line and along a transverse line at the level of the anterior superior iliac spine at hours 0 to 6. RESULTS: Although there were statistically significant differences between treatments within the earlier part of the administration period, by hour 6 the difference in extent of sensory deficit to cold failed to reach statistical significance along the axillary line (mean = 0.9 cm; SD = 6.8; 95% confidence interval –2.0 to 3.8; P = .515) and transverse line (mean = 2.5 cm; SD = 10.1; 95% confidence interval –1.8 to 6.8; P = .244). Although the difference between treatments was statistically significant at various early time points for the horizontal, vertical, and estimated area measurements of both cold and mechanical pressure sensory deficits, no comparison remained statistically significant by hour 6. CONCLUSIONS: No evidence was found in this study involving healthy volunteers to support the hypothesis that changing the local anesthetic administration technique (continuous basal versus hourly bolus) when using ropivacaine 0.2% and TAP catheters at 8 mL/h and 24 mL every 3 hours significantly influences the cutaneous effects after 6 hours of administration. Additional research is required to determine whether changing variables (eg, local anesthetic concentration, basal infusion rate, bolus dose volume, and/or interval) would provide different results." @default.
• W2617142754 created "2017-06-05" @default.
• W2617142754 creator A5000306300 @default.
• W2617142754 creator A5030911639 @default.
• W2617142754 creator A5038820885 @default.
• W2617142754 creator A5039307141 @default.
• W2617142754 creator A5055729686 @default.
• W2617142754 creator A5058096285 @default.
• W2617142754 creator A5079709524 @default.
• W2617142754 creator A5081041323 @default.
• W2617142754 creator A5085615582 @default.
• W2617142754 date "2017-04-01" @default.
• W2617142754 modified "2023-10-18" @default.
• W2617142754 title "Continuous Transversus Abdominis Plane Nerve Blocks" @default.
• W2617142754 cites W1554275969 @default.
• W2617142754 cites W1813613571 @default.
• W2617142754 cites W1869257061 @default.
• W2617142754 cites W1878253363 @default.
• W2617142754 cites W1894200338 @default.
• W2617142754 cites W1952513228 @default.
• W2617142754 cites W1965090528 @default.
• W2617142754 cites W1974505957 @default.
• W2617142754 cites W1988332515 @default.
• W2617142754 cites W1992023497 @default.
• W2617142754 cites W1999061992 @default.
• W2617142754 cites W2006330665 @default.
• W2617142754 cites W2015865219 @default.
• W2617142754 cites W2018628127 @default.
• W2617142754 cites W2026130326 @default.
• W2617142754 cites W2035460895 @default.
• W2617142754 cites W2038878445 @default.
• W2617142754 cites W2041439514 @default.
• W2617142754 cites W2043177715 @default.
• W2617142754 cites W2047332067 @default.
• W2617142754 cites W2050006573 @default.
• W2617142754 cites W2054306621 @default.
• W2617142754 cites W2065273254 @default.
• W2617142754 cites W2068559035 @default.
• W2617142754 cites W2116865097 @default.
• W2617142754 cites W2120666477 @default.
• W2617142754 cites W2123562744 @default.
• W2617142754 cites W2138480821 @default.
• W2617142754 cites W2144355216 @default.
• W2617142754 cites W2171166736 @default.
• W2617142754 cites W2332304752 @default.
• W2617142754 cites W2400347672 @default.
• W2617142754 cites W2401625349 @default.
• W2617142754 cites W2406420943 @default.
• W2617142754 cites W2515013919 @default.
• W2617142754 cites W2530746066 @default.
• W2617142754 doi "https://doi.org/10.1213/ane.0000000000001939" @default.
• W2617142754 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5362121" @default.
• W2617142754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28319550" @default.
• W2617142754 hasPublicationYear "2017" @default.
• W2617142754 type Work @default.
• W2617142754 sameAs 2617142754 @default.
• W2617142754 citedByCount "18" @default.
• W2617142754 countsByYear W26171427542017 @default.
• W2617142754 countsByYear W26171427542018 @default.
• W2617142754 countsByYear W26171427542019 @default.
• W2617142754 countsByYear W26171427542020 @default.
• W2617142754 countsByYear W26171427542021 @default.
• W2617142754 countsByYear W26171427542022 @default.
• W2617142754 crossrefType "journal-article" @default.
• W2617142754 hasAuthorship W2617142754A5000306300 @default.
• W2617142754 hasAuthorship W2617142754A5030911639 @default.
• W2617142754 hasAuthorship W2617142754A5038820885 @default.
• W2617142754 hasAuthorship W2617142754A5039307141 @default.
• W2617142754 hasAuthorship W2617142754A5055729686 @default.
• W2617142754 hasAuthorship W2617142754A5058096285 @default.
• W2617142754 hasAuthorship W2617142754A5079709524 @default.
• W2617142754 hasAuthorship W2617142754A5081041323 @default.
• W2617142754 hasAuthorship W2617142754A5085615582 @default.
• W2617142754 hasBestOaLocation W26171427542 @default.
• W2617142754 hasConcept C126322002 @default.
• W2617142754 hasConcept C141071460 @default.
• W2617142754 hasConcept C2778994108 @default.
• W2617142754 hasConcept C2780269707 @default.
• W2617142754 hasConcept C42219234 @default.
• W2617142754 hasConcept C43376680 @default.
• W2617142754 hasConcept C44249647 @default.
• W2617142754 hasConcept C71924100 @default.
• W2617142754 hasConceptScore W2617142754C126322002 @default.
• W2617142754 hasConceptScore W2617142754C141071460 @default.
• W2617142754 hasConceptScore W2617142754C2778994108 @default.
• W2617142754 hasConceptScore W2617142754C2780269707 @default.
• W2617142754 hasConceptScore W2617142754C42219234 @default.
• W2617142754 hasConceptScore W2617142754C43376680 @default.
• W2617142754 hasConceptScore W2617142754C44249647 @default.
• W2617142754 hasConceptScore W2617142754C71924100 @default.
• W2617142754 hasIssue "4" @default.
• W2617142754 hasLocation W26171427541 @default.
• W2617142754 hasLocation W26171427542 @default.
• W2617142754 hasLocation W26171427543 @default.
• W2617142754 hasLocation W26171427544 @default.
• W2617142754 hasOpenAccess W2617142754 @default.
• W2617142754 hasPrimaryLocation W26171427541 @default.
• W2617142754 hasRelatedWork W2061629741 @default.

• next